Mirae Asset Global Investments’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.4K Buy
8,698
+2,166
+33% +$6.47K ﹤0.01% 1459
2026
Q1
$20.1K Buy
6,532
+1,462
+29% +$6.21K ﹤0.01% 1433
2025
Q4
$18.3K Buy
5,070
+1,658
+49% +$7.23K ﹤0.01% 1549
2025
Q3
$12.9K Buy
3,412
+279
+9% +$1.08K ﹤0.01% 1543
2025
Q2
$12.1K Buy
3,133
+556
+22% +$3.01K ﹤0.01% 1464
2025
Q1
$13.7K Buy
2,577
+207
+9% +$1.31K ﹤0.01% 1435
2024
Q4
$18.2K Buy
+2,370
New +$18.1K ﹤0.01% 1433
2024
Q2
Sell
-26,666
Closed -$271K 1565
2024
Q1
$271K Buy
+26,666
New +$271K ﹤0.01% 2150
2023
Q4
Sell
-28,352
Closed -$73.7K 2526
2023
Q3
$73.7K Buy
28,352
+124
+0.4% +$356 ﹤0.01% 2517
2023
Q2
$99.6K Buy
28,228
+7,437
+36% +$33.4K ﹤0.01% 2511
2023
Q1
$87.7K Buy
+20,791
New +$247K ﹤0.01% 2464

Other funds holding ALT

Mirae Asset Global Investments's ALT Position: Q2 2026 in Review

Mirae Asset Global Investments increased its Altimmune (ALT) stake by 33% in Q2 2026, buying an estimated $6.47K and bringing the position to 8,698 shares worth $26.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1459.

Mirae Asset Global Investments first reported a position in ALT in Q1 2023 and has held it in 11 quarters since. The position peaked at $271K in Q1 2024. 39 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Mirae Asset Global Investments held 8,698 shares of Altimmune worth $26.4K as of Q2 2026.
  • Mirae Asset Global Investments bought 2,166 Altimmune shares in Q2 2026, an estimated $6.47K.
  • Altimmune made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1459 holding.
  • Mirae Asset Global Investments first reported a position in Altimmune in Q1 2023 and has held it in 11 quarters since.
  • Mirae Asset Global Investments's Altimmune position peaked at $271K in Q1 2024.
  • 39 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.